Stay updated on Remibrutinib for CSU: Clinical Trial

Sign up to get notified when there's something new on the Remibrutinib for CSU: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Remibrutinib for CSU: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page revision changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T03:23:45.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The record presents details of the completed Phase 3 REMIX-2 trial of remibrutinib for chronic spontaneous urticaria, including its design, eligibility criteria, outcomes, and study locations. It also provides results-related publications, record dates, and study documents.
    Difference
    100%
    Check dated 2026-11-11T02:16:52.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label updates from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T01:08:49.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces changes to terminology used across NIH content. The page still displays a 403 Forbidden error, and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:00:09.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The revision identifier in the footer of the 403 Forbidden page changed from v3.7.0 to v3.7.1; the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-07T01:07:26.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message with a minimal header and a Home link, replacing the previous study content and links.
    Difference
    18%
    Check dated 2026-09-23T00:59:30.000Z thumbnail image

Stay in the know with updates to Remibrutinib for CSU: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Remibrutinib for CSU: Clinical Trial page.